Daniela Gabbia
Via Marzolo 5
Padova, 35131, Italy
Padova, 35131, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
Conventional and hydrolysable PEGs: comparative evaluation of tissue accumulation, biodistribution and toxicological profile.
Journal: Biomaterials science
Published: September 07, 2026
Natural Compounds for Counteracting GI and Liver Diseases.
Journal: International journal of molecular sciences
Published: June 30, 2026
Design, Synthesis, and Pharmacokinetic Profiling of Fluorinated Reversible N-Alkyl Carbamate Derivatives of Psilocin for Sub-Hallucinogenic Brain Exposure.
Journal: Journal of medicinal chemistry
Published: January 26, 2026
Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanisms.
Journal: Pharmacological research
Published: October 30, 2025
An update on novel investigational agents for the treatment of primary biliary cholangitis.
Journal: Expert opinion on investigational drugs
Published: October 13, 2025
High-payload trastuzumab-drug conjugates achieved through hydrophilic Y-shaped pendant PEG linkers for a potent and selective antitumor response.
Journal: International journal of biological macromolecules
Published: September 15, 2025
Natural Remedies for Irritable Bowel Syndrome: A Comprehensive Review of Herbal-Based Therapies.
Journal: International journal of molecular sciences
Published: August 29, 2025
Reviewing novel findings and advances in diagnoses and treatment of primary biliary cholangitis.
Journal: Expert review of gastroenterology & hepatology
Published: July 30, 2025
Functional and therapeutic effects of Glabrescione B delivery by liposomes on Hedgehog-dependent tumors.
Journal: Drug delivery and translational research
Published: July 28, 2025
Oleocanthalic acid improves MASH features via a NOX1-dependent mechanism.
Journal: European journal of pharmacology
Published: March 11, 2025
Discovery of selective, metabolically stable pyrazole-based FLT3 inhibitors for the treatment of acute myeloid leukemia.
Journal: RSC medicinal chemistry
Published: December 03, 2024
Recent Advances in miRNA-Based Therapy for MASLD/MASH and MASH-Associated HCC.
Journal: International journal of molecular sciences
Published: October 03, 2024
Last Updated: 09/26/2026